Skip to Main Content

Paper Details

Phase II Trial of Dabrafenib Plus Trametinib in Relapsed/Refractory <i>BRAF</i> V600-Mutant Pediatric High-Grade Glioma.
J Clin Oncol
12
2023
Author NameAffiliation
Darren HargraveUCL Great Ormond Street Institute of Child Health
Felix SahmUniversity Hospital Heidelberg
Felix SahmHopp Children's Cancer Center (KiTZ), German Cancer Research Center (DKFZ), Heidelberg University Hospital
Felix SahmGerman Cancer Research Center (DKFZ), Heidelberg University Hospital
Felix SahmUniversity Hospital Heidelberg
Felix SahmGerman Cancer Research Center (DKFZ), Heidelberg University Hospital
Felix SahmHopp Children's Cancer Center (KiTZ), German Cancer Research Center (DKFZ), Heidelberg University Hospital
Eric BouffetThe Hospital for Sick Children, University of Toronto
Roger J PackerChildren's National Medical Center
Roger J PackerChildren's National Medical Center
Olaf WittHopp Children's Cancer Center (KiTZ), German Cancer Research Center (DKFZ), Heidelberg University Hospital
Olaf WittHopp Children's Cancer Center (KiTZ), German Cancer Research Center (DKFZ), Heidelberg University Hospital
Kenneth J CohenThe Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
  • 1 - 13

Datasets

Release 1.2